iSpecimen Inc. financial data

Symbol
ISPC on Nasdaq
Industry
Services-Commercial Physical & Biological Research
Location
8 Cabot Road, Suite 1800, Woburn, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 98.3 % -74.4%
Debt-to-equity 88.2 % +297%
Return On Equity -139 % -125%
Return On Assets -74 % -46%
Operating Margin -93.9 % +7.21%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 963K shares -89.4%
Common Stock, Shares, Outstanding 830K shares -90.9%
Entity Public Float 10.4M USD -20.5%
Common Stock, Value, Issued 83 USD -90.8%
Weighted Average Number of Shares Outstanding, Basic 687K shares +51.6%
Weighted Average Number of Shares Outstanding, Diluted 687K shares +51.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 10.4M USD +0.74%
Selling and Marketing Expense 3.5M USD -6.74%
General and Administrative Expense 5.31M USD -11.4%
Costs and Expenses 20.1M USD -2.92%
Operating Income (Loss) -9.76M USD +6.53%
Nonoperating Income (Expense) 235K USD -7.52%
Net Income (Loss) Attributable to Parent -9.52M USD +6.5%
Earnings Per Share, Basic 1.48 USD/shares +54.9%
Earnings Per Share, Diluted -2.1 USD/shares +54.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.75M USD -35.6%
Marketable Securities, Current 6.21M USD
Cash, Cash Equivalents, and Short-term Investments 1.75M USD -69.1%
Accounts Receivable, after Allowance for Credit Loss, Current 974K USD -42.9%
Assets, Current 4.66M USD -49%
Property, Plant and Equipment, Net 103K USD -29.7%
Operating Lease, Right-of-Use Asset 342K USD +46.3%
Other Assets, Noncurrent 213K USD
Assets 11.3M USD -30.9%
Accounts Payable, Current 4.06M USD +77.9%
Accrued Liabilities, Current 1.02M USD -0.54%
Liabilities, Current 6.27M USD +78.2%
Operating Lease, Liability, Noncurrent 281K USD +289%
Liabilities 6.55M USD +82.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax 41 USD -99.8%
Retained Earnings (Accumulated Deficit) -65.8M USD -16.9%
Stockholders' Equity Attributable to Parent 4.71M USD -62.9%
Liabilities and Equity 11.3M USD -30.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.07M USD +26.7%
Net Cash Provided by (Used in) Financing Activities -119K USD -275%
Net Cash Provided by (Used in) Investing Activities 1.94M USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 831K shares -90.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.75M USD -35.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 4.47K USD +26.3%
Deferred Tax Assets, Valuation Allowance 15.2M USD +33.1%
Deferred Tax Assets, Gross 15.4M USD +30.8%
Operating Lease, Liability 324K USD +38.2%
Depreciation 67K USD -37.9%
Payments to Acquire Property, Plant, and Equipment 9.14K USD +13.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -9.52M USD +31.8%
Lessee, Operating Lease, Liability, to be Paid 399K USD +62.9%
Property, Plant and Equipment, Gross 428K USD -25.3%
Operating Lease, Liability, Current 42.5K USD -73.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 66.7K USD -61.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 18.2K USD -56.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +33.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 75.3K USD +601%
Lessee, Operating Lease, Liability, to be Paid, Year Three 76.4K USD +160%
Deferred Tax Assets, Operating Loss Carryforwards 12.6M USD +24.3%
Preferred Stock, Shares Authorized 50M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 80.2K USD
Additional Paid in Capital 70.5M USD +2.22%
Amortization of Intangible Assets 47.9K USD
Share-based Payment Arrangement, Expense 18.1K USD -40.8%
Interest Expense 20.8K USD -81.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%